Exane Derivatives’s Cameco CCJ Stock Holding History

Exane Derivatives’s Portfolio CCJ Stock Details CCJ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	$5.19M	Buy	247,958 +12,313	+5%	+$311K	2.98%	4
2022 Q1	$6.85M	Sell	235,645 -116,746	-33%	-$2.74M	1.93%	5
2021 Q4	$7.66M	Buy	352,391 +276,053	+362%	+$6.68M	1.85%	9
2021 Q3	$1.66M	Buy	76,338 +2,164	+3%	+$40.9K	0.4%	48
2021 Q2	$1.32M	Sell	74,174 -70,178	-49%	-$1.32M	0.3%	73
2021 Q1	$2.4M	Buy	144,352 +37,438	+35%	+$575K	0.69%	34
2020 Q4	$1.43M	Buy	106,914 +2,928	+3%	+$31.3K	0.42%	49
2020 Q3	$1.05M	Buy	+103,986	New	+$1.13M	0.3%	76
2020 Q2	–	Sell	-18,236	Closed	-$139K	–	695
2020 Q1	$139K	Buy	18,236 +10,869	+148%	+$89.1K	0.04%	240
2019 Q4	$64.6K	Buy	7,367 +7,300	+10,896%	+$67.5K	0.01%	350
2019 Q3	$636	Sell	67 -50,000	-100%	-$469K	﹤0.01%	568
2019 Q2	$537K	Sell	50,067 -49,000	-49%	-$528K	0.09%	167
2019 Q1	$1.17M	Sell	99,067 -70,000	-41%	-$841K	0.23%	97
2018 Q4	$1.92M	Buy	169,067 +148,999	+742%	+$1.73M	0.34%	78
2018 Q3	$227K	Buy	20,068 +20,000	+29,412%	+$210K	0.04%	230
2018 Q2	$771	Hold	68	–	–	﹤0.01%	547
2018 Q1	$603	Hold	68	–	–	﹤0.01%	495
2017 Q4	$628	Hold	68	–	–	﹤0.01%	500
2017 Q3	$657	Hold	68	–	–	﹤0.01%	468
2017 Q2	$619	Buy	+68	New	+$676	﹤0.01%	493
2017 Q1	–	Sell	-5,423	Closed	-$56.8K	–	591
2016 Q4	$56.8K	Sell	5,423 -5,164	-49%	-$46.6K	0.01%	289
2016 Q3	$90.6K	Sell	10,587 -1,008	-9%	-$9.7K	0.01%	250
2016 Q2	$127K	Sell	11,595 -48,691	-81%	-$578K	0.02%	227
2016 Q1	$776K	Sell	60,286 -8,263	-12%	-$98.8K	0.1%	105
2015 Q4	$843K	Sell	68,549 -18,180	-21%	-$233K	0.12%	87
2015 Q3	$1.03M	Sell	86,729 -14,133	-14%	-$191K	0.13%	89
2015 Q2	$1.45M	Buy	100,862 +5,699	+6%	+$90K	0.16%	74
2015 Q1	$1.33M	Sell	95,163 -3,739	-4%	-$55.9K	0.15%	79
2014 Q4	$1.63M	Buy	+98,902	New	+$1.7M	0.23%	78

Other funds holding CCJ

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

LIM

Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Exane Derivatives's CCJ Position: Q2 2022 in Review

Exane Derivatives increased its Cameco (CCJ) stake by 5.2% in Q2 2022, buying an estimated $311K and bringing the position to 247,958 shares worth $5.19M. The position accounts for 2.98% of the portfolio, ranked #4.

Exane Derivatives first reported a position in CCJ in Q4 2014 and has held it in 29 quarters since. The position peaked at $7.66M in Q4 2021. 415 funds tracked by Wall St. Rank hold CCJ as of Q2 2022.

Exane Derivatives held 247,958 shares of Cameco worth $5.19M as of Q2 2022.
Exane Derivatives bought 12,313 Cameco shares in Q2 2022, an estimated $311K.
Cameco made up 2.98% of Exane Derivatives's portfolio in Q2 2022, its #4 holding.
Exane Derivatives first reported a position in Cameco in Q4 2014 and has held it in 29 quarters since.
Exane Derivatives's Cameco position peaked at $7.66M in Q4 2021.
415 funds tracked by Wall St. Rank held Cameco as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.